IRadimed Corporation
IRMDNASDAQHealthcare● Active
$94.39
+$1.32(+1.42%)
Market Cap$1.2B
P/E Ratio—
52W High$107.9
52W Low$55.109
IRadimed Corporation (IRMD) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · IRMD · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $83.81M | $73.24M | $65.56M | $53.30M | $41.81M |
| Cost of Revenue | $19.49M | $16.89M | $15.40M | $12.02M | $9.76M |
| Gross Profit | $64.32M | $56.35M | $50.16M | $41.28M | $32.05M |
| Gross Margin %(computed) | 76.75% | 76.94% | 76.50% | 77.45% | 76.65% |
| Operating Expenses | |||||
| R&D Expenses | $2.98M | $2.83M | $2.86M | $2.28M | $1.91M |
| G&A Expenses | $17.78M | $15.94M | $15.12M | $10.70M | $9.77M |
| Total Operating Expenses | $38.18M | $34.39M | $30.12M | $25.65M | $22.23M |
| Operating Income | $26.15M | $21.96M | $20.04M | $15.63M | $9.82M |
| Operating Margin %(computed) | 31.20% | 29.99% | 30.56% | 29.32% | 23.48% |
| Interest Income | $0.00M | $2.19M | $1.86M | $0.58M | $0.03M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | $28.36M | $24.28M | $21.74M | $16.18M | $9.84M |
| Income Tax Expense | $5.88M | $5.04M | $4.55M | $3.35M | $0.51M |
| Net Income | $22.48M | $19.23M | $17.19M | $12.83M | $9.33M |
| Net Margin %(computed) | 26.82% | 26.26% | 26.22% | 24.07% | 22.30% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $1.77 | $1.52 | $1.36 | $1.02 | $0.76 |
| Wtd Avg Shares | 12.72M | 12.67M | 12.60M | 12.56M | 12.35M |
| EBITDA | $28.53M | $22.78M | $20.80M | $16.30M | $11.22M |
| EBITDA Margin %(computed) | 34.04% | 31.11% | 31.73% | 30.58% | 26.84% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · M
Explore more IRadimed Corporation data
About IRadimed Corporation (IRMD) Income Statement
IRadimed Corporation (IRMD) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, IRMD reported revenue of $0.08B, gross profit of $0.06B (gross margin 76.75%), and net income of $0.02B — a net profit margin of 26.82%.
Frequently asked questions
IRMD · 4 questionsIRadimed Corporation (IRMD) reported revenue of $0.08B for 2025, up 14.4% year-over-year.
IRMD revenueIRMD salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08